Srecko Sabalic

Prof. Srecko Sabalic

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Vilim MolnarVilim Molnar
Vilim Molnar
VMVid Matišić
Vid Matišić
IKIvan Kodvanj
Ivan Kodvanj
RBRoko Bjelica
Roko Bjelica
ŽJŽeljko Jeleč
Željko Jeleč
Dragan PrimoracDragan Primorac
Dragan Primorac
Osteoarthritis is a common cause of disability worldwide. Although commonly referred to as a disease of the joint cartilage, osteoarthritis affects all joint tissues equally. The pathogenesis of this degenerative process is not completely understood; however, a low-grade inflammation leading to an imbalance between anabolic and katabolic processes is a well-established factor. The complex network of cytokines regulating these processes and cell communication has a central role in the development and progression of osteoarthritis. Concentrations of both proinflammatory and anti-inflammatory cytokines were found to be altered depending on the osteoarthritis stage and activity. In this review, we analyzed individual cytokines involved in the immune processes with an emphasis on their function in osteoarthritis.


16 December 2021 in Genes
Verified
Journal Article
Open access
PDF file
LZLucija Zenic
Lucija Zenic
DPDenis Polancec
Denis Polancec
DHDamir Hudetz
Damir Hudetz
ŽJŽeljko Jeleč
Željko Jeleč
EREduard Rod
Eduard Rod
Dragan PrimoracDragan Primorac
Dragan Primorac
Mesenchymal stem/stromal cells or medicinal signaling cells (MSC)-based therapy holds promise as a beneficial strategy for treating knee OA (osteoarthritis), but there is no standardized protocols nor mechanistic understanding. In order to gain a better insight into the human MSC from adipose tissue applied for autologous OA treatment, we performed extensive comparative immunophenotyping of the stromal vascular fraction from lipoaspirate or microfragmented lipoaspirates by polychromatic flow cytometry and investigated the cellular components considered responsible for cartilage regeneration. We found an enrichment of the regenerative cellular niche of the clinically applied microfragmented stromal vascular fraction. Sex-related differences were observed in the MSC marker expression and the ratio of the progenitor cells from fresh lipoaspirate, which, in female patients, contained a higher expression of CD90 on the three progenitor cell types including pericytes, a higher expression of CD105 and CD146 on CD31highCD34high endothelial progenitors as well as of CD73 on supra-adventitialadipose stromal cells. Some of these MSC-expression differences were present after microfragmentation and indicated a differential phenotype pattern of the applied MSC mixture in female and male patients. Our results provide a better insight into the heterogeneity of the adipose MSC subpopulations serving as OA therapeutics, with an emphasis on interesting differences between women and men.

29 November 2011 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
RKRobert Karlo
Robert Karlo
BDBoris Dželalija
Boris Dželalija
BŽBožidar Župančić
Božidar Župančić
IBIvan Bačić
Ivan Bačić
TDTihomir Dunatov
Tihomir Dunatov
Goran AugustinGoran Augustin
Goran Augustin

19 September 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Vilim MolnarVilim Molnar
Vilim Molnar
ŽJŽeljko Jeleč
Željko Jeleč
EREduard Rod
Eduard Rod
DHDamir Hudetz
Damir Hudetz
Petar BrlekPetar Brlek
Petar Brlek
Dragan PrimoracDragan Primorac
Dragan Primorac
Background: Knee osteoarthritis (OA) is a leading cause of disability, with limited therapies that modify both symptoms and structural degeneration. Autologous microfragmented adipose tissue (MFAT) has emerged as a promising regenerative option, especially in phenotypically distinct OA subgroups. This randomized controlled trial evaluated the clinical and structural efficacy of intra-articular MFAT versus hyaluronic acid (HA) in patients with early to moderate inflammatory phenotype knee OA. Methods: Fifty-three patients were randomized in a 2:1 ratio to receive either MFAT (n = 35) or HA (n = 18). Patients were followed-up for six months post-injection and evaluated using patient-reported outcome measures (KOOS, WOMAC, VAS) and delayed gadolinium-enhanced MRI of cartilage (dGEMRIC). A responder analysis defined structural response as ≥10% increase in dGEMRIC in ≥3 of 7 predefined cartilage regions. Results: Both MFAT and HA led to statistically significant improvements in clinical scores and cartilage glycosaminoglycan content. MFAT showed greater mean improvements across most clinical and dGEMRIC measures, although without reaching statistical significance, except for KOOS Symptoms (MFAT: +25.0 vs. HA: +12.7, p = 0.008). Responder-level analysis revealed that all patients who demonstrated structural response also experienced clinically meaningful pain improvement (KOOS Pain ≥ 10), while no patient showed structural benefit without parallel symptomatic relief. Conclusions: MFAT led to greater improvement in symptoms related to joint stiffness, swelling, and crepitus compared to HA, reflecting its potential benefit in targeting the inflammatory features of knee OA. Importantly, HA also led to significant clinical and structural improvements, supporting its continued role as a standard-of-care comparator in knee OA management. Furthermore, the correlation between dGEMRIC and clinical response suggests its utility as a predictive biomarker of treatment success.

14 January 2023 in Medical & Biological Engineering & Computing
Verified
Journal Article
Closed access
PDF file
Petra BesedićPetra Besedić
Petra Besedić
JKJanoš Kodvanj
Janoš Kodvanj
DBDejan Blažević
Dejan Blažević
SSSrecko Sabalic
Srecko Sabalic